Latest News

STAT Plus: Pharmalittle: Trump offers to help VA negotiate for J&J drug; Senate panel to mark up drug pricing bill

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite a steady downpour that is making for a soggy feeling at the Pharmalot campus. Nonetheless, our spirits are sunny. How so? We will remind you of a favorite saying of the Morning Mayor: Every brand new day should be unwrapped like a precious gift. So while you tug on the ribbon, we will brew another cup of stimulation and forage for items of interest. Speaking of which, here are a few. Hope your journey goes well and, as always, do keep in touch. …

GlaxoSmithKline (GSK) plans to team with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for new drugs, establishing a new lab in San Francisco and spending up to $67 million over five years, STAT reports. Jennifer Doudna, the University of California, Berkeley, researcher who co-invented the CRISPR enzyme technology, will help lead the effort, along with Jonathan Weissman, a UC San Francisco researcher who has been using CRISPR to understand the function of individual human genes and how they work together.

Continue to STAT Plus to read the full story…

Source link

Related posts

Childhood episode of pancreatitis may up risk for diabetes later


Global Chronic Obstructive Pulmonary Disease Analysis, Size, Share, Growth, Trends & Forecast, 2019-2027 –


Medical News Today: Saw palmetto and testosterone facts


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy